ASCO 2021 Highlights on Treatment-Naïve Higher-Risk MDS: CR/OS Data From VERONA Study on Venetoclax With Azacitidine

54 views
June 29, 2021
0 Comments
Login to view comments. Click here to Login
Hematologic Oncology